What are the major opportunities in the Zynlonta market? What are the strategies for the Zynlonta market?

For detailed insights on the major opportunities and strategies in the Zynlonta market, Read More

How does the Zynlonta market relate to the overall economy and other similar markets?

For detailed insights on Zynlonta's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Zynlonta market growth? SWOT analysis of the Zynlonta market.

For detailed insights on the key dynamics influencing the Zynlonta market growth and SWOT analysis of the Zynlonta industry, Read More

Item added to cart!

Published : December 2025

Pages :

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00 $3367.00

Purchase This Report Download Sample PDF

Purchase This Report

Zynlonta Global Market Report 2025

Name: Zynlonta Global Market Report 2025
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

By Indication (Diffuse Large B-Cell Lymphoma (DLBCL), High-Grade B-Cell Lymphoma, DLBCL Arising From Follicular Lymphoma), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By End-User (Adult Patients, Geriatic Patients)

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

What Is Covered Under Zynlonta Market?

Zynlonta (generic name: loncastuximab tesirine-lpyl) is a prescription medication used in oncology. It is a targeted therapy classified as an antibody-drug conjugate (ADC). Zynlonta is specifically indicated for treating relapsed or refractory large B-cell lymphoma, including diffuse large B-cell lymphoma (DLBCL), after two or more lines of systemic therapy.

The main types of indications for zynlonta are diffuse large B-cell lymphoma (DLBCL), high-grade B-cell lymphoma, and DLBCL arising from follicular lymphoma. Diffuse Large B-Cell Lymphoma (DLBCL) is an aggressive type of non-Hodgkin lymphoma (NHL) marked by the rapid growth of large B-cells in the lymphatic system, commonly treated with chemotherapy and immunotherapy such as rituximab. It is distributed through various channels such as hospital pharmacies, retail pharmacies, and online pharmacies, catering to various end users such as adult patients and geriatric patients.

Zynlonta Market Size and growth rate 2025 to 2029: Graph

What Is The Zynlonta Market Size 2025 And Growth Rate?

The zynlonta market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to the increasing prevalence of cancer, high demand for antibody-based cancer therapies, increasing incidence of breast cancer, rising healthcare expenditure, and a growing elderly population.

What Is The Zynlonta Market Growth Forecast?

The zynlonta market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to the rising incidence of lymphomas, increase in approvals and indications, growth in clinical trials, surge in combination therapies, growing awareness and diagnosis, and rising demand for targeted therapies. Major trends in the forecast period include technology advancements in immunotherapy, integration of biomarkers in treatment, innovation in antibody-drug conjugates, integration with digital health solutions, and developing advanced drug formulations.

Book your 30 minutes free consultation with our research experts

How Is The Zynlonta Market Segmented?

The zynlonta market covered in this report is segmented –

1) By Indication: Diffuse Large B-Cell Lymphoma (DLBCL); High-Grade B-Cell Lymphoma; DLBCL Arising From Follicular Lymphoma

2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies

3) By End-User: Adult Patients; Geriatic Patients

What Is Driving The Zynlonta Market? Rising Lymphoma Incidence Fuels Growth Of The Market

The rising incidence of lymphomas is expected to propel the growth of the zynlonta market going forward. Lymphomas refer to a group of cancers originating in the lymphatic system and primarily affecting lymphocytes, a type of white blood cell found in lymph nodes, the spleen, bone marrow, and other lymphoid tissues. The rising incidence of lymphomas can be attributed to factors such as an aging population, immune system suppression, environmental exposures, viral infections, genetic predispositions, and lifestyle choices. Zynlonta is a targeted therapy used to treat relapsed or refractory large B-cell lymphoma (LBCL) by delivering a chemotherapy drug directly to cancerous B cells, effectively killing them. For instance, according to the American Cancer Society, a US-based non-profit organization, the estimated number of new lymphoma cancer cases increased from 89,010 in 2022 to 89,380 in 2023. Therefore, the rising incidence of lymphomas drive the growth of the zynlonta market.

Who Are The Major Players In The Global Zynlonta Market?

Major companies operating in the zynlonta market are ADC Therapeutics SA; Avid Bioservices Inc

What Are The Key Trends Of The Global Zynlonta Market? Technological Advancements Propel The Market Growth

The key trend in the zynlonta market is developing innovative therapies, such as combination therapies, to enhance treatment efficacy and improve patient outcomes in cancer care. Combination therapies refer to using two or more treatments, such as drugs or therapies, to enhance therapeutic effectiveness and target multiple aspects of a disease. For instance, in April 2024, ADC Therapeutics, a Switzerland-based biotechnology company specializing in the development of antibody-drug conjugates (ADCs) for the treatment of hematological malignancies and solid tumors, has announced updates on their LOTIS-7 clinical trial, which evaluates Zynlonta (loncastuximab tesirine-lpyl) in combination with bispecific antibodies such as glofitamab or mosunetuzumab. The trial aims to treat heavily pretreated patients with relapsed/refractory B-cell non-Hodgkin lymphoma (r/r B-NHL).

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Zynlonta Market? ADC Therapeutics And Sobi Join Forces To Enhance Zynlonta Commercialization

In July 2022, ADC Therapeutics S.A., a Switzerland-based biotechnology company that focused on creating advanced, targeted antibody-drug conjugates (ADCs) for treating hematologic cancers and solid tumors, partnered with Swedish Orphan Biovitrum AB (Sobi). This strategic alliance aims to enhance the development and commercialization of Zynlonta, broadening its availability across different regions and securing essential funding for ongoing clinical trials. Swedish Orphan Biovitrum AB is a Sweden-based biopharmaceutical company specializing in hematology, immunology, and specialty care treatments.

Regional Analysis For The Global Zynlonta Market

North America was the largest region in the zynlonta market in 2024. The regions covered in the zynlonta market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the zynlonta market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Zynlonta Market?

The zynlonta market consists of sales of combination therapies, diagnostic and companion tools, supportive care medications, injection kits, and biosimilars. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Zynlonta Industry?

The zynlonta market research report is one of a series of new reports from The Business Research Company that provides zynlonta market statistics, including the zynlonta industry global market size, regional shares, competitors with the zynlonta market share, detailed zynlonta market segments, market trends, and opportunities, and any further data you may need to thrive in the zynlonta industry. This zynlonta market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Author : Abhilash Pyata

Zynlonta Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	Included ?
Revenue Forecast In 2034	Included ?
Growth Rate	Included ?
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	The zynlonta market covered in this report is segmented – 1) By Indication: Diffuse Large B-Cell Lymphoma (DLBCL); High-Grade B-Cell Lymphoma; DLBCL Arising From Follicular Lymphoma 2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies 3) By End-User: Adult Patients; Geriatic Patients
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	ADC Therapeutics SA; Avid Bioservices Inc
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Zynlonta Market Characteristics

3. Zynlonta Market Biologic Drug Characteristics

3.1. Molecule Type

3.2. Route Of Administration (ROA)

3.3. Mechanism Of Action (MOA)

3.4. Safety And Efficacy

4. Zynlonta Market Trends And Strategies

5. Zynlonta Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

6. Global Zynlonta Growth Analysis And Strategic Analysis Framework

6.1. Global Zynlonta PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

6.2. Analysis Of End Use Industries

6.3. Global Zynlonta Market Growth Rate Analysis

6.4. Global Zynlonta Historic Market Size and Growth, 2019 - 2024, Value ($ Million)

6.5. Global Zynlonta Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Million)

6.6. Global Zynlonta Total Addressable Market (TAM)

7. Global Zynlonta Pricing Analysis & Forecasts

8. Zynlonta Market Segmentation

8.1. Global Zynlonta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Diffuse Large B-Cell Lymphoma (DLBCL)

High-Grade B-Cell Lymphoma

DLBCL Arising From Follicular Lymphoma

8.2. Global Zynlonta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

8.3. Global Zynlonta Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Adult Patients

Geriatic Patients

9. Global Zynlonta Epidemiology Of Clinical Indications

9.1. Drug Side Effects

9.2. Incidence And Prevalence of Clinical Indications

10. Zynlonta Market Regional And Country Analysis

10.1. Global Zynlonta Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

10.2. Global Zynlonta Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

11. Asia-Pacific Zynlonta Market

11.1. Asia-Pacific Zynlonta Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Zynlonta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

11.3. Asia-Pacific Zynlonta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

11.4. Asia-Pacific Zynlonta Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

12. China Zynlonta Market

12.1. China Zynlonta Market Overview

12.2. China Zynlonta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

12.3. China Zynlonta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

12.4. China Zynlonta Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

13. India Zynlonta Market

13.1. India Zynlonta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

13.2. India Zynlonta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

13.3. India Zynlonta Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

14. Japan Zynlonta Market

14.1. Japan Zynlonta Market Overview

14.2. Japan Zynlonta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

14.3. Japan Zynlonta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

14.4. Japan Zynlonta Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

15. Australia Zynlonta Market

15.1. Australia Zynlonta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

15.2. Australia Zynlonta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

15.3. Australia Zynlonta Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

16. South Korea Zynlonta Market

16.1. South Korea Zynlonta Market Overview

16.2. South Korea Zynlonta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

16.3. South Korea Zynlonta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

16.4. South Korea Zynlonta Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

17. Western Europe Zynlonta Market

17.1. Western Europe Zynlonta Market Overview

17.2. Western Europe Zynlonta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

17.3. Western Europe Zynlonta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

17.4. Western Europe Zynlonta Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

18. UK Zynlonta Market

18.1. UK Zynlonta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

18.2. UK Zynlonta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

18.3. UK Zynlonta Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

19. Germany Zynlonta Market

19.1. Germany Zynlonta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

19.2. Germany Zynlonta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

19.3. Germany Zynlonta Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

20. France Zynlonta Market

20.1. France Zynlonta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

20.2. France Zynlonta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

20.3. France Zynlonta Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

21. Eastern Europe Zynlonta Market

21.1. Eastern Europe Zynlonta Market Overview

21.2. Eastern Europe Zynlonta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

21.3. Eastern Europe Zynlonta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

21.4. Eastern Europe Zynlonta Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

22. North America Zynlonta Market

22.1. North America Zynlonta Market Overview

22.2. North America Zynlonta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

22.3. North America Zynlonta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

22.4. North America Zynlonta Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

23. USA Zynlonta Market

23.1. USA Zynlonta Market Overview

23.2. USA Zynlonta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

23.3. USA Zynlonta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

23.4. USA Zynlonta Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

24. Canada Zynlonta Market

24.1. Canada Zynlonta Market Overview

24.2. Canada Zynlonta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

24.3. Canada Zynlonta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

24.4. Canada Zynlonta Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

25. South America Zynlonta Market

25.1. South America Zynlonta Market Overview

25.2. South America Zynlonta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

25.3. South America Zynlonta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

25.4. South America Zynlonta Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

26. Middle East Zynlonta Market

26.1. Middle East Zynlonta Market Overview

26.2. Middle East Zynlonta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

26.3. Middle East Zynlonta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

26.4. Middle East Zynlonta Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

27. Africa Zynlonta Market

27.1. Africa Zynlonta Market Overview

27.2. Africa Zynlonta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

27.3. Africa Zynlonta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

27.4. Africa Zynlonta Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

28. Zynlonta Market Competitive Landscape And Company Profiles

28.1. Zynlonta Market Competitive Landscape

28.2. Zynlonta Market Company Profiles

28.2.1. ADC Therapeutics SA Overview, Products and Services, Strategy and Financial Analysis

28.2.2. Avid Bioservices Inc Overview, Products and Services, Strategy and Financial Analysis

29. Global Zynlonta Market Pipeline Analysis

29.1. High Level Clinic Trail Information

30. Global Zynlonta Market Competitive Benchmarking And Dashboard

31. Key Mergers And Acquisitions In The Zynlonta Market

32. Recent Developments In The Zynlonta Market

33. Zynlonta Market High Potential Countries, Segments and Strategies

33.1 Zynlonta Market In 2029 - Countries Offering Most New Opportunities

33.2 Zynlonta Market In 2029 - Segments Offering Most New Opportunities

33.3 Zynlonta Market In 2029 - Growth Strategies

33.3.1 Market Trend Based Strategies

33.3.2 Competitor Strategies

34. Appendix

34.1. Abbreviations

34.2. Currencies

34.3. Historic And Forecast Inflation Rates

34.4. Research Inquiries

34.5. The Business Research Company

34.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Million

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Million

Table 3: Global Zynlonta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 4: Global Zynlonta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 5: Global Zynlonta Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 6: Global Zynlonta Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 7: Global Zynlonta Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 8: Asia-Pacific, Zynlonta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 9: Asia-Pacific, Zynlonta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 10: Asia-Pacific, Zynlonta Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 11: China, Zynlonta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 12: China, Zynlonta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 13: China, Zynlonta Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 14: India, Zynlonta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 15: India, Zynlonta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 16: India, Zynlonta Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 17: Japan, Zynlonta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 18: Japan, Zynlonta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 19: Japan, Zynlonta Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 20: Australia, Zynlonta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 21: Australia, Zynlonta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 22: Australia, Zynlonta Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 23: South Korea, Zynlonta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 24: South Korea, Zynlonta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 25: South Korea, Zynlonta Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 26: Western Europe, Zynlonta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 27: Western Europe, Zynlonta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 28: Western Europe, Zynlonta Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 29: UK, Zynlonta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 30: UK, Zynlonta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 31: UK, Zynlonta Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 32: Germany, Zynlonta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 33: Germany, Zynlonta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 34: Germany, Zynlonta Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 35: France, Zynlonta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 36: France, Zynlonta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 37: France, Zynlonta Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 38: Eastern Europe, Zynlonta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 39: Eastern Europe, Zynlonta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 40: Eastern Europe, Zynlonta Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 41: North America, Zynlonta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 42: North America, Zynlonta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 43: North America, Zynlonta Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 44: USA, Zynlonta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 45: USA, Zynlonta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 46: USA, Zynlonta Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 47: Canada, Zynlonta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 48: Canada, Zynlonta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 49: Canada, Zynlonta Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 50: South America, Zynlonta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 51: South America, Zynlonta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 52: South America, Zynlonta Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 53: Middle East, Zynlonta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 54: Middle East, Zynlonta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 55: Middle East, Zynlonta Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 56: Africa, Zynlonta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 57: Africa, Zynlonta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 58: Africa, Zynlonta Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 59: ADC Therapeutics SA Financial Performance

Table 60: Avid Bioservices Inc Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Million

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Million

Figure 3: Global Zynlonta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 4: Global Zynlonta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 5: Global Zynlonta Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 6: Global Zynlonta Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 7: Global Zynlonta Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 8: Asia-Pacific, Zynlonta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 9: Asia-Pacific, Zynlonta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 10: Asia-Pacific, Zynlonta Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 11: China, Zynlonta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 12: China, Zynlonta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 13: China, Zynlonta Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 14: India, Zynlonta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 15: India, Zynlonta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 16: India, Zynlonta Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 17: Japan, Zynlonta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 18: Japan, Zynlonta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 19: Japan, Zynlonta Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 20: Australia, Zynlonta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 21: Australia, Zynlonta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 22: Australia, Zynlonta Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 23: South Korea, Zynlonta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 24: South Korea, Zynlonta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 25: South Korea, Zynlonta Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 26: Western Europe, Zynlonta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 27: Western Europe, Zynlonta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 28: Western Europe, Zynlonta Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 29: UK, Zynlonta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 30: UK, Zynlonta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 31: UK, Zynlonta Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 32: Germany, Zynlonta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 33: Germany, Zynlonta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 34: Germany, Zynlonta Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 35: France, Zynlonta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 36: France, Zynlonta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 37: France, Zynlonta Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 38: Eastern Europe, Zynlonta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 39: Eastern Europe, Zynlonta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 40: Eastern Europe, Zynlonta Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 41: North America, Zynlonta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 42: North America, Zynlonta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 43: North America, Zynlonta Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 44: USA, Zynlonta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 45: USA, Zynlonta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 46: USA, Zynlonta Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 47: Canada, Zynlonta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 48: Canada, Zynlonta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 49: Canada, Zynlonta Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 50: South America, Zynlonta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 51: South America, Zynlonta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 52: South America, Zynlonta Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 53: Middle East, Zynlonta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 54: Middle East, Zynlonta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 55: Middle East, Zynlonta Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 56: Africa, Zynlonta Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 57: Africa, Zynlonta Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 58: Africa, Zynlonta Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 59: ADC Therapeutics SA Financial Performance

Figure 60: Avid Bioservices Inc Financial Performance

Global Complete Nutrition Products Market Landscape: Trends and Market Share to 2029

Competitive and Market Trend Analysis of Conjugate Vaccine Industry Through 2029

Industry Trends Show Cosmeceuticals Market Set to Expand at 8.8% CAGR Until 2029

Strategic Report on Cosmetic Ingredients Market: Growth Opportunities and Emerging Challenges

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

Discover key trends and market dynamics in the Mycobacterium Tuberculosis Market with 2025 insights from The Business Research Company.

Discover key trends and market dynamics in the Smoking Cessation & Nicotine De-addiction Products Market with 2025 insights from The Business Research Company.

Discover key trends and market dynamics in the MSI-H and DMMR Market with 2025 insights from The Business Research Company.

Immuno-Oncology Drugs Global Market Report 2025 – By Type (Immune Checkpoint Inhibitors, Immune System Modulators, Other Monoclonal Antibodies, Cancer Vaccines, Others), By Therapeutic Application (Melanoma, Lung Cancer,...

Oncology Molecular Diagnostics Global Market Report 2025 – By Product (Instruments, Reagents, Other Products), By Technology (Polymerase Chain Reaction (PCR), In-situ Hybridization (ISH), Isothermic Nucleic Acid Amplific...

Oncology Biosimilars Global Market Report 2025 – By Drug Type (Monoclonal Antibody, Immunomodulators, Hematopoietic Agents, Granulocyte Colony-Stimulating Factor (G-CSF)), By Cancer Type (Breast Cancer, Colorectal Cancer...

Interventional Oncology Devices Global Market Report 2025 – By Product (Embolization Devices, Ablation Devices, Support Devices), By procedure (Thermal Tumor Ablation, Non-Thermal Tumor Ablation, Transcatheter Arterial C...

Clinical Oncology Next Generation Sequencing Global Market Report 2025 – By Technology (Ion Semiconductor Sequencing, Pyro-Sequencing, Synthesis Sequencing, Real Time Sequencing, Ligation Sequencing, Reversible Dye Termi...

Community Oncology Services Global Market Report 2025 – By Type (Small Community Oncology Clinics, Medium Community Oncology Clinics, Large Community Oncology Clinics), By Cancer Type (Breast Cancer, Lung Cancer, Kidney ...

Oncology Devices Global Market Report 2025 – By Device Type (Brachytherapy Devices, Endoscopic Devices), By Therapy (Chemotherapy, Hormone Therapy, Biotherapy/Immunotherapy, Radition Therapy), By End User (Hospitals, Can...

Frequently Asked Questions

What is the definition of the Zynlonta market?

How will the Zynlonta market drivers and restraints affect the market dynamics? What forces will shape the Zynlonta industry going forward?

The Zynlonta market major growth driver - Rising Lymphoma Incidence Fuels Growth Of The Market. For further insights on the Zynlonta market, request a sample here

What is the forecast market size or the forecast market value of the Zynlonta market?

The Zynlonta market size has grown strongly in recent years. The zynlonta market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to the increasing prevalence of cancer, high demand for antibody-based cancer therapies, increasing incidence of breast cancer, rising healthcare expenditure, and a growing elderly population. The zynlonta market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to the rising incidence of lymphomas, increase in approvals and indications, growth in clinical trials, surge in combination therapies, growing awareness and diagnosis, and rising demand for targeted therapies. Major trends in the forecast period include technology advancements in immunotherapy, integration of biomarkers in treatment, innovation in antibody-drug conjugates, integration with digital health solutions, and developing advanced drug formulations. For further insights on the Zynlonta market, request a sample here

How is the Zynlonta market segmented?

The zynlonta market covered in this report is segmented –
1) By Indication: Diffuse Large B-Cell Lymphoma (DLBCL); High-Grade B-Cell Lymphoma; DLBCL Arising From Follicular Lymphoma
2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
3) By End-User: Adult Patients; Geriatic Patients For further insights on the Zynlonta market, request a sample here

Which region has the largest share of the Zynlonta market? What are the other regions covered in the report?

Who are the major players in the Zynlonta market?

Major companies operating in the zynlonta market are ADC Therapeutics SA; Avid Bioservices Inc . For further insights on the Zynlonta market, request a sample here.

What are the key trends in the Zynlonta market?

Major trends in the Zynlonta market include Technological Advancements Propel The Market Growth. For further insights on the Zynlonta market, request a sample here.